VIVIMED LABS LTD. Share Price

₹ 5.99

+0.00 (0.00%)
1D
Last updated 02 Nov, 2026, 10:46 IST
BSE: 532660
|
Pharmaceuticals
Share price over the last 1 day rose from 5.99 to 5.99, ranging between 5.99 and 5.99.
--
0.00% up today
--
1D LOW
1D HIGH

VIVIMED LABS LTD. Stock Insights

Latest Earning
Op Profit TrendDown by 788.16% QoQ
Latest Earning
Net Profit TrendDown by 788.94% QoQ
Latest Earning
Revenue TrendUp by 11.01% QoQ
Stock Performance
OutperformingBeat Nifty by 11.24 % in last 1 month
Shareholding Pattern
PromoterPromoter decreased stake by 2.51%
Shareholding Pattern
FIIFII increased stake by 0.23%
VIVIMED LABS LTD. stock performance
Open--
High--
Low--
Prev. close₹5.99
VIVIMED LABS LTD. trading activity
Volume--
Average traded price--
Last traded time10:46:12 02 Nov
Last traded quantity50
Circuit
L
H
₹5.88
₹6.10
52-week
L
H
₹4.76
₹27.99
Mkt Cap Cr
49.67
P/E
-0.28
P/B
0.0
ROA
-23.42%
ROE
83.81%
ROCE
-27.87%
EV/EBITDA
-3.02

Based on fundamentals, this stock's

Performance: 5 out of 5, Excellent
Performance
Excellent
Vivimed Labs. outperforming all market indices
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Vivimed Labs. appears overvalued compared to its peers
Earnings: 2 out of 5, Poor
Earnings
Poor
Vivimed Labs. earnings have been degrowing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEEV/EBITDA
Sun Pharmaceutical Industries4,24,202.4238.614.759.61%13.79%18.65%22.27
Divis Laboratories2,57,902.7390.3115.7614.6%15.32%19.56%58.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%33.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%54.77
Zydus Lifesciences1,23,685.4926.934.568.57%18.59%17.35%16.42
Dr. Reddy's Laboratories1,11,868.0340.542.884.79%7.21%8.58%19.05
Cipla1,11,647.7239.123.156.6%8.18%10.8%21.03
Mankind Pharma1,02,195.6245.155.817.82%12.76%14.68%25.01
Aurobindo Pharma96,951.1826.132.566.34%9.25%11.76%12.38
Lupin91,870.1616.454.0714.47%23.76%24.88%9.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

VIVIMED LABS LTD. Company Background

ISIN
INE526G01021
Sector Market Cap
₹ 49.67 Cr

Vivimed Labs Limited is an India-based company engaged in the manufacture of Active Pharmaceutical ingredients (API’s), Intermediates and Nutraceutical ingredients with predominance in exports. The Company is primarily engaged in Pharma segment. In addition to generic business, the Company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management. Its manufacturing facilities are equipped to deliver a range of dosage delivery formats that include capsules, tablets, syrups & liquids, sprays & ointments.

VIVIMED LABS LTD. Financial Highlights

  • Revenue: VIVIMED LABS LTD. reported revenue of ₹76.31 crore in FY26 vs ₹120.64 crore in FY25. It showed a decrease of 36.75% on a yearly basis.
  • Operating Profit: VIVIMED LABS LTD. reported an operating loss of ₹176.34 crore in FY26 vs ₹31.85 crore in FY25. It showed a decrease of 453.66% on a year-on-year basis.
  • Net Profit: VIVIMED LABS LTD. reported a net loss of ₹176.47 crore in FY26 vs ₹31.96 crore in FY25. It showed a decrease of 452.16% on a yearly basis.

VIVIMED LABS LTD. Quarterly Result Highlights

  • VIVIMED LABS LTD. reported revenue of ₹17.75 crore in Mar 2026, compared with ₹15.99 crore in Dec 2025, representing an increase of 11.01% on a quarter-on-quarter (QoQ) basis.
  • VIVIMED LABS LTD. reported an operating loss of ₹146.99 crore in Mar 2026, compared with ₹16.55 crore in Dec 2025, representing a decrease of 788.16% on a quarter-on-quarter (QoQ) basis.
  • VIVIMED LABS LTD. reported a loss of ₹147.12 crore in Mar 2026, compared with ₹16.55 crore in Dec 2025, reflecting a decrease of 788.94% on a QoQ basis.
  • The earnings per share (EPS) of VIVIMED LABS LTD. stood at ₹3.85 during Mar 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
7.57%
FII
1.64%
Other DII
0.00%
Retail and other
90.78%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Jun 20251.64%
Sep 20251.64%
Dec 20251.64%
Mar 20261.64%

VIVIMED LABS LTD. Investment Returns

1 day
--
1 week
--
1 month
--
1 year
--
3 years
--
5 years
--

VIVIMED LABS LTD. Share Price History

VIVIMED LABS LTD. share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹5.99 / ₹5.99
-1.96%
23 Oct 26
₹6.11 / ₹6.11
-1.93%
21 Oct 26
₹6.39 / ₹6.23
-1.89%
19 Oct 26
₹6.35 / ₹6.35
-1.85%
Show more

VIVIMED LABS LTD. Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹116.27₹149.07₹187.10₹237.29
Other Income₹4.37₹9.98₹0.97₹1.27
Total Revenue₹120.64₹159.05₹188.07₹238.56
Total Expenses₹152.49₹204.87₹518.72₹303.39
Profit Before Tax-₹31.85-₹45.82-₹330.65-₹64.83
Tax₹0.11-₹0.38-₹2.12₹2.82
Profit After Tax-₹31.96-₹45.45-₹328.54-₹67.65
EPS - Basic-₹3.85-₹5.48-₹39.62-₹8.16
EPS - Diluted-₹3.74-₹5.32-₹38.46-₹7.92

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹31.50-₹45.82-₹330.65-₹64.28
Income before WC changes-₹8.33-₹23.45-₹186.34-₹6.23
Change in Assets₹6.62-₹5.24₹170.80₹22.20
Change in Liabilities₹0.05₹4.60₹50.86₹11.58
Change in WC₹6.67-₹0.64₹221.66₹33.77
Cash flow from Operations-₹1.75-₹23.99₹35.32₹27.54
Cash flow from Investing-₹4.53₹28.29-₹4.97-₹16.41
Cash flow from Financing₹4.96-₹6.03-₹33.78-₹10.38
Total Cash Flow-₹1.32-₹1.74-₹3.43₹0.75
Cash (Start of the year)₹2.03₹3.76₹7.18₹6.43
Cash (End of the year)₹0.71₹2.03₹3.76₹7.18

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹593.28₹608.33₹656.06₹758.75
Current Assets₹327.56₹342.58₹338.99₹507.27
Total Assets₹920.84₹950.91₹995.05₹1,266.01
Current Liabilities₹408.20₹410.33₹424.09₹373.39
Net Current Asset-₹80.64-₹67.74-₹85.10₹133.88
Non-Current Liabilities₹547.81₹546.05₹531.54₹528.34
Equity Capital-₹35.17-₹5.46₹39.42₹364.29
Total Equity & Liabilities₹920.84₹950.91₹995.05₹1,266.01

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹103.60₹136.80₹176.83₹218.37
Other Income₹4.19₹9.57₹0.24₹1.26
Total Revenue₹107.79₹146.37₹177.06₹219.63
Total Expenses₹139.29₹190.75₹507.19₹284.56
Profit Before Tax-₹31.50-₹44.38-₹330.13-₹64.94
Tax₹0.00₹0.00-₹2.12₹2.82
Profit After Tax-₹31.50-₹44.38-₹328.01-₹67.75
EPS - Basic-₹3.80-₹5.35-₹39.56-₹8.17
EPS - Diluted-₹3.69-₹5.20-₹38.40-₹7.93

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹30.92-₹44.38-₹330.13-₹64.38
Income before WC changes-₹9.76-₹24.07-₹187.94-₹7.40
Change in Assets₹27.09-₹6.76₹170.80₹17.70
Change in Liabilities-₹11.60-₹65.70₹50.01₹15.01
Change in WC₹15.49-₹72.46₹220.80₹32.71
Cash flow from Operations₹5.73-₹96.52₹32.87₹25.31
Cash flow from Investing-₹4.06₹99.83-₹1.60-₹11.34
Cash flow from Financing-₹2.53-₹5.51-₹34.70-₹13.21
Total Cash Flow-₹0.86-₹2.20-₹3.43₹0.76
Cash (Start of the year)₹1.14₹3.35₹6.78₹6.02
Cash (End of the year)₹0.29₹1.15₹3.35₹6.78

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹391.18₹405.75₹524.66₹629.97
Current Assets₹247.78₹275.72₹271.16₹441.82
Total Assets₹638.95₹681.47₹795.82₹1,071.79
Current Liabilities₹393.21₹391.17₹412.49₹365.82
Net Current Asset-₹145.43-₹115.45-₹141.33₹75.99
Non-Current Liabilities₹187.26₹200.89₹250.02₹248.69
Equity Capital₹58.49₹89.41₹133.31₹457.27
Total Equity & Liabilities₹638.95₹681.47₹795.82₹1,071.79
* All values are in INR Crore
VIVIMED LABS LTD. market depth
Bid quantityBid priceAsk priceAsk quantity
005.8854024
005.99100
0000
0000
0000
Total bid quantity0
Total ask quantity54,124
VIVIMED LABS LTD. technical summary
Bearish indicators2
Neutral indicators2
Bullish indicators4
OverallSlightly Bullish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
44.49
Neutral
ATR (14)
0.22
Neutral
STOCH(9,6)
0
Bullish
STOCH RSI (14)
0
Bullish
ADX(9)
31.91
Bearish
UO(9)
19.71
Bullish
ROC(12)
-3.07
Bearish
WillR(14)
-92.75
Bullish
Period
Simple value
Exponential vaue
5D
6.23
6.21
10D
6.55
6.31
20D
6.17
6.26
50D
6.1
6.1
100D
5.88
6.06
Volume trend — traded volume by day
2 Nov0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

VIVIMED LABS LTD.
Pharmaceuticals
Add Stock
Add Another

VIVIMED LABS LTD. Returns Calculator

Top Gainers

KRBL Share Price
₹401.45
+38.45 (+10.59%)
MARICO Share Price
₹878.40
+79.85 (+10%)
BALRAMCHIN Share Price
₹654.80
+54.9 (+9.15%)
TRIDENT Share Price
₹23.79
+1.58 (+7.11%)
AEGISLOG Share Price
₹1177.10
+77 (+7%)
See more

Top Losers

KEC Share Price
₹316.35
-32.65 (-9.36%)
GNFC Share Price
₹465.05
-45.95 (-8.99%)
PRAJIND Share Price
₹254.63
-16.5 (-6.09%)
AIAENG Share Price
₹3389.70
-217.6 (-6.03%)
GESHIP Share Price
₹1536.50
-63.9 (-3.99%)
See more

VIVIMED LABS LTD. Share Price FAQs

Please be aware that VIVIMED LABS LTD. stock prices are subject to continuous fluctuations due to various factors.